Citation Impact 2023
Journal Impact Factor: 4.4
5-year Journal Impact Factor: 4.9
Source Normalized Impact per Paper (SNIP): 1.294
SCImago Journal Rank (SJR): 1.518
Speed 2023
Submission to first editorial decision (median days): 9
Submission to acceptance (median days): 111
Usage 2023
Downloads: 3,331,819
Altmetric mentions: 1,885
Articles
Page 148 of 155
-
Citation: Arthritis Research & Therapy 2001 3(Suppl 2):P117
-
Anti-Fcgamma receptor (FcgammaR) autoantibodies (Ab) delay apoptosis of polymorphonuclear cells (PMN) in systemic autoimmune diseases by inducing the production of G-CSF and GM-CSF
Citation: Arthritis Research & Therapy 2001 3(Suppl 2):P115 -
Nucleosome binding by serum amyloid P component from SLE patients
Citation: Arthritis Research & Therapy 2001 3(Suppl 2):P113 -
Increased apoptosis level in late stages of rheumatoid arthritis correlates with macrophage number
Citation: Arthritis Research & Therapy 2001 3(Suppl 2):P111 -
The exchange of one single amino acid at position 71 of the DR4 beta-chain leads to significant differences in antigen processing and presentation of a human autoantigen chaperoned by a member of the HSP70 family
Citation: Arthritis Research & Therapy 2001 3(Suppl 2):P109 -
Analysis of VH and VL mRNA in single synovial and peripheral B/plasma cells of patients with rheumatoid arthritis
Citation: Arthritis Research & Therapy 2001 3(Suppl 2):P107 -
Infiltrate analysis of rheumatoid synovial tissue before and after high does chemotherapy and autologous stem cell transplantation
Citation: Arthritis Research & Therapy 2001 3(Suppl 2):P096 -
Effect of osteoprotegerin and pamidronate treatment in transgenic mice overexpressing human TNF
Citation: Arthritis Research & Therapy 2001 3(Suppl 2):P094 -
IL-18 blockade is a potential disease-modifying therapy for rheumatoid arthritis
Citation: Arthritis Research & Therapy 2001 3(Suppl 2):P092 -
Altered migratory capacity of polymorphonuclear leucocytes as an effect of TNF-alpha blockade in patients with rheumatoid arthritis
Citation: Arthritis Research & Therapy 2001 3(Suppl 2):P090 -
Adenoviral-based overexpression of TIMP-1 reduces tissue damage in the joints TNF-transgenic mice
Citation: Arthritis Research & Therapy 2001 3(Suppl 2):P088 -
Disorders of the system of hemostasis and biochemical parameters of NZB/NZW F1 mice
Citation: Arthritis Research & Therapy 2001 3(Suppl 2):P086 -
Antibodies to β2-glycoprotein I, prothrombin and antithrombin III as markers of the antiphospholipid syndrome severity
Citation: Arthritis Research & Therapy 2001 3(Suppl 2):P084 -
Oxidation of beta2-glycoprotein I (beta2GPI) by the hydroxyl radical alters phospholipid binding and modulates recognition by anti-beta2GPI autoantibodies
Citation: Arthritis Research & Therapy 2001 3(Suppl 2):P082 -
Improving an anti-beta2 GPI ELISA by reducing the influence of a blocking agent
Citation: Arthritis Research & Therapy 2001 3(Suppl 2):P080 -
The infectious origin of the antiphospholipid syndrome: induction by passive transfer of anti- β2GPI Abs induced by common bacteria
Citation: Arthritis Research & Therapy 2001 3(Suppl 2):P078 -
Comparative analysis of anti-histone and anti-chromatin antibody specificity in lupus erythematosus cell-positive and -negative sera and their relation to disease activity
Citation: Arthritis Research & Therapy 2001 3(Suppl 2):P076 -
Recombinant anti-P proteins antibodies isolated from human autoimmune library: reactivity, specificity and epitope recognition
Citation: Arthritis Research & Therapy 2001 3(Suppl 2):P074 -
Induction of immune responses in inbreed mice by immunizations with the complementary 289-308 La/SSB epitope
Citation: Arthritis Research & Therapy 2001 3(Suppl 2):P072 -
Comparison of different methods for the detection of the fine specificity of anti-Ro/SSA response
Citation: Arthritis Research & Therapy 2001 3(Suppl 2):P070 -
Impaired T-cell rsponse to subsequent TCR-stimulation after anti-CD3 induced proliferation
Citation: Arthritis Research & Therapy 2001 3(Suppl 2):P061 -
Persistence of plasma cells in the kidneys of autoimmune NZB/W mice
Citation: Arthritis Research & Therapy 2001 3(Suppl 2):P057 -
Leflunomide leads to inhibition of transendothelial migration
Citation: Arthritis Research & Therapy 2001 3(Suppl 2):P055 -
Responses of the rat immune system to arthritogenic adjuvant-oil
Citation: Arthritis Research & Therapy 2001 3(Suppl 2):P053 -
In adjuvant-induced arthritis the disease-triggering adjuvant squalene accumulates in draining lymph nodes but not affected joints
Citation: Arthritis Research & Therapy 2001 3(Suppl 2):P051 -
Enrichment of CD8+ CD28- cytotoxic T cells in circulating lymphocytes of patients with ankylosing spondylitis
Citation: Arthritis Research & Therapy 2001 3(Suppl 2):P049 -
The release of an ERK-activating factor from cartilage explants in response to trauma
Citation: Arthritis Research & Therapy 2001 3(Suppl 2):P047 -
Patterns of differentially expressed genes in synovial tissue from RA and OA patients and from normal joints
Citation: Arthritis Research & Therapy 2001 3(Suppl 2):P045 -
Invasion of synoviocytes is inhibited by gene transfer of TNF-BP or IL10 in an in vitro invasion model
Citation: Arthritis Research & Therapy 2001 3(Suppl 2):P043 -
Defective Rap1 activation in synovial fluid T cells from patients with rheumatoid arthritis
Citation: Arthritis Research & Therapy 2001 3(Suppl 2):P041 -
Peripheral corticotropin releasing hormone signaling is mediated by Type 1alpha receptors in early human inflammatory arthritis
Citation: Arthritis Research & Therapy 2001 3(Suppl 2):P039 -
Global analysis of gene expression in unseparated and CD8+ cells from bronchoalveolar lavage of patients with scleroderma lung disease
Citation: Arthritis Research & Therapy 2001 3(Suppl 2):P037 -
Spontaneous activation of JNK-1 and PI-3 kinase can be induced in lupus-like chronic GVHD in the P->F1 model
Citation: Arthritis Research & Therapy 2001 3(Suppl 2):P035 -
Dynamics of early synovial cytokine expression in rodent collagen-induced arthritis: a therapeutic study
Citation: Arthritis Research & Therapy 2001 3(Suppl 2):P025 -
The molecular mechanism of osteoclastogenesis: ODF/RANKL-dependent and independent pathways
Citation: Arthritis Research & Therapy 2001 3(Suppl 2):L024 -
Mice deficient in leptin (ob/ob) or in liptin receptor (db/db) have a milder form of antigen-induced arthritis
Citation: Arthritis Research & Therapy 2001 3(Suppl 2):P023 -
Intracellular expression of CXCR3 on rheumatoid arthritis synovial tissue cells
Citation: Arthritis Research & Therapy 2001 3(Suppl 2):P021 -
Substance P and its cleavage products: effects on interleukin-1 secretion of rheumatoid arthritis monocytes/macrophages
Citation: Arthritis Research & Therapy 2001 3(Suppl 2):P019 -
Functional and biologic evaluation of immunoregulatory cytokines in the immunopathologic lesion of Sjogren's syndrome
Citation: Arthritis Research & Therapy 2001 3(Suppl 2):P017 -
Differential effect of corticosteroid therapy on the cytoplasmic cytokine expression in CD4 and CD8 positive T cells from lupus patients
Citation: Arthritis Research & Therapy 2001 3(Suppl 2):P015 -
The stress protein BiP is a major autoantigen in rheumatoid arthritis
Citation: Arthritis Research & Therapy 2001 3(Suppl 2):P013 -
Aberrant expression of the autoantigen hnRNP-A2/RA33 in the joints of patients with rheumatoid arthritis and TNF-alpha transgenic mice: a clue to autoimmunity?
Citation: Arthritis Research & Therapy 2001 3(Suppl 2):P011 -
The role of DNA in the pathogenesis of SLE
Citation: Arthritis Research & Therapy 2001 3(Suppl 2):L009 -
Anti-skin anti-intercellular antibodies in juvenile idiopathic arthritis
Citation: Arthritis Research & Therapy 2001 3(Suppl 2):P009 -
Chromosome segregation one hundred years after Mendel's rediscovery
Citation: Arthritis Research & Therapy 2001 3(Suppl 2):L007 -
ELISA detection of antifilaggrin autoantibodies onto deiminated recombinant rat filaggrin: a highly effective test for the diagnosis of rheumatoid arthritis
Citation: Arthritis Research & Therapy 2001 3(Suppl 2):P007 -
The integration of functional genomics, combinatorial chemistry and nanotechnology into a miniaturized drug discovery process
Citation: Arthritis Research & Therapy 2001 3(Suppl 2):L005 -
Autoreactivity patterns in rheumatoid arthritis
Citation: Arthritis Research & Therapy 2001 3(Suppl 2):P005 -
Clinical sensitivity of antibodies against cyclic citrulinated peptide in patients with rheumatoid arthritis
Citation: Arthritis Research & Therapy 2001 3(Suppl 2):P003 -
The impact of DNA chip technology on molecular medicine
Citation: Arthritis Research & Therapy 2001 3(Suppl 2):L001